CRIS Current Research Information System

POLUZZI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.958
AS - Asia 9.376
EU - Europa 9.249
AF - Africa 750
SA - Sud America 589
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 7
Totale 30.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.815
SG - Singapore 3.031
CN - Cina 2.790
IT - Italia 2.426
GB - Regno Unito 1.980
DE - Germania 1.480
VN - Vietnam 1.440
SE - Svezia 839
HK - Hong Kong 791
IN - India 492
BR - Brasile 438
RU - Federazione Russa 437
UA - Ucraina 363
FR - Francia 340
NL - Olanda 312
IE - Irlanda 305
KR - Corea 304
CI - Costa d'Avorio 281
TG - Togo 213
JP - Giappone 155
ZA - Sudafrica 143
FI - Finlandia 128
EE - Estonia 107
CA - Canada 95
AT - Austria 83
JO - Giordania 73
BE - Belgio 72
ID - Indonesia 72
AR - Argentina 70
BG - Bulgaria 60
CH - Svizzera 56
ES - Italia 51
PL - Polonia 48
TR - Turchia 46
MX - Messico 37
NG - Nigeria 35
SC - Seychelles 32
PT - Portogallo 31
AU - Australia 30
HR - Croazia 28
BD - Bangladesh 22
GR - Grecia 19
EC - Ecuador 18
CO - Colombia 17
LT - Lituania 16
TW - Taiwan 16
SA - Arabia Saudita 15
RO - Romania 14
PH - Filippine 13
TH - Thailandia 13
UZ - Uzbekistan 13
CL - Cile 12
IR - Iran 12
PE - Perù 12
IQ - Iraq 11
MA - Marocco 11
IL - Israele 10
CZ - Repubblica Ceca 9
LB - Libano 9
NZ - Nuova Zelanda 9
DK - Danimarca 8
EG - Egitto 8
KE - Kenya 8
PY - Paraguay 8
VE - Venezuela 8
MY - Malesia 7
AE - Emirati Arabi Uniti 6
PK - Pakistan 6
RS - Serbia 6
SI - Slovenia 6
TN - Tunisia 6
SM - San Marino 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
DZ - Algeria 4
XK - ???statistics.table.value.countryCode.XK??? 4
KH - Cambogia 3
KZ - Kazakistan 3
MT - Malta 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
CY - Cipro 2
ET - Etiopia 2
GA - Gabon 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NO - Norvegia 2
AD - Andorra 1
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
Totale 30.950
Salva come PNG Salva come JPEG
Città #
Singapore 1.985
Southend 1.694
Ashburn 1.342
Fairfield 914
Chandler 901
Hong Kong 760
Hefei 726
Santa Clara 638
Dong Ket 595
Bologna 497
Wilmington 459
Princeton 417
Frankfurt am Main 415
Woodbridge 407
Seattle 385
Houston 371
Ann Arbor 362
Beijing 357
Seoul 301
Cambridge 296
Dublin 295
Abidjan 281
Boardman 266
Ho Chi Minh City 243
Lomé 213
Dallas 207
Jacksonville 204
Los Angeles 196
Milan 152
Hanoi 149
Westminster 146
Nanjing 140
Rome 135
Tokyo 129
Padova 127
Berlin 118
Redmond 114
New York 95
Buffalo 93
Helsinki 92
Saint Petersburg 84
Turin 83
Redondo Beach 81
Shenyang 80
Bremen 79
Medford 77
Jinan 76
Amman 73
Brussels 68
Bengaluru 66
San Diego 66
London 64
Florence 61
Munich 58
Mülheim 57
Shanghai 56
Sofia 56
São Paulo 56
Jakarta 51
Falkenstein 50
The Dalles 48
Falls Church 47
Hebei 47
Nanchang 46
Vienna 45
Toronto 43
Zhengzhou 42
Bern 39
Dearborn 38
Nuremberg 38
Tianjin 37
Biella 36
Changsha 36
Chicago 36
Guangzhou 35
Jiaxing 33
Modena 32
Phoenix 32
Secaucus 32
Hangzhou 31
Redwood City 31
Abeokuta 30
Council Bluffs 30
Des Moines 30
Olalla 30
Yubileyny 30
Istanbul 28
San Francisco 28
Warsaw 28
San Venanzo 27
Palermo 26
Cesena 25
Brooklyn 24
Paris 24
Bühl 22
Amsterdam 21
Biên Hòa 21
Düsseldorf 21
Haiphong 21
Porto 21
Totale 19.850
Salva come PNG Salva come JPEG
Nome #
'Use of antipsychotics in children and adolescents: A picture from the ARITMO population-based European cohort study' 679
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 522
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. 469
ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance 454
ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance 315
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems 295
Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project 284
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 276
Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions 265
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 241
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 233
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 231
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors 231
Farmacoutilizzazione in ospedale: analisi delle variabilità in una realtà regionale 226
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems 225
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 219
Antibacterial macrolides: a drug class with a complex pharmacological profile 209
Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study 208
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy 200
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 198
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 196
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database. 196
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health 192
A 3 year survey on the use of antibacterial agents in five Italian hospitals. 190
Predictors of antipsychotic prescription in a Northern Italian District (Bologna) 190
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 187
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System 185
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 185
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 184
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System 183
Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System 183
Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct 176
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database. 175
An update on the first decade of the European centralized procedure: how many innovative drugs? 174
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 173
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 172
Association between Paraesthesia and Local Anesthetics: Data Mining of the Public Version of the FDA Adverse Event Reporting System, 171
Pattern of drug use among preterm neonates: Results from an Italian neonatal intensive care unit 171
An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. 170
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 168
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 166
Social and clinical descriptors of antipsychotic prescription 166
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 166
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project 166
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database 166
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 165
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 164
Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting 163
Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective 162
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System 160
Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development 160
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 159
Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics 158
Drug-induced Kounis syndrome: A matter of pharmacovigilance 157
Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database 156
Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe 156
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis 155
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics 153
Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection 151
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis 151
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements 151
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 148
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region 148
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System 147
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 146
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 146
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study 145
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies 144
A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. 144
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 144
Dapagliflozin and cardiovascular outcomes: anything else to DECLARE? 144
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 144
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS 143
Predictors of non-adherence with oral bisphosphonates: an Italian retrospective cohort study on administrative databases 143
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance 141
Farmaci lassativi e purganti 140
Excipients in medicinal products used in gastroenterology as a possible cause of side effects. 140
Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System 140
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 140
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 139
Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy 139
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 138
Antibiotic use in Italian hospitals 2002-2004. 137
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 136
Developing a Method To Identify Prescribing Profiles of Antihypertensive Drugs in General Practice. 135
Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. 135
Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. 135
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment 134
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy 133
The hERG K+ channel: target and antitarget strategies in drug development. 133
Pattern of NSAID use in the Italian general population: a questionnaire-based survey. 133
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. 133
Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies 132
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 132
The adherence to antihypertensive treatments: an Italian survey by using prescription databases. 132
Diabetes is associated with decreased migraine risk: A nationwide cohort study 132
Initial treatment of hypertension and adherence to therapy in general practice in Italy 132
Apparato Gastroenterico 131
Prescription patterns of antiepileptic drugs in young women: development of a tool to distinguish between epilepsy and psychiatric disorders 131
Association between the use of proton pump inhibitors and cardiovascular events: A note of caution 131
Totale 18.352
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 300
Totale 90.547
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.800 0 0 0 0 0 151 66 175 218 150 167 873
2021/20223.831 401 121 201 192 318 226 160 267 169 229 919 628
2022/20234.598 505 599 350 549 276 322 171 304 725 189 385 223
2023/20242.067 123 226 227 297 161 209 88 344 46 133 127 86
2024/20256.024 379 780 562 367 933 372 376 259 141 375 313 1.167
2025/20267.191 1.153 1.361 1.309 906 1.512 950 0 0 0 0 0 0
Totale 31.652